Opcon-A .2675 mg/mL (Naphazoline hydrochloride and Pheniramine maleate SOLUTION/ DROPS) .2675 mg/mL

Opcon-A .2675 mg/mL is an ophthalmic solution containing Naphazoline hydrochloride and Pheniramine maleate. It is commonly used for eye redness and irritation relief. This product is manufactured by Bausch & Lomb Incorporated in the USA.

Strength

.2675 mg/mL

Pack Size

2 BOTTLE, DROPPER in 1 CARTON (24208-430-45) / 15 mL in 1 BOTTLE, DROPPER

Manufacturer / TM Owner

Bausch & Lomb Incorporated

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Opcon-A .2675 mg/mL is typically used to relieve eye redness and irritation. The combination of Naphazoline hydrochloride and Pheniramine maleate works to constrict blood vessels and reduce allergic reactions in the eyes. This solution is often recommended for conditions like conjunctivitis or seasonal allergies that cause eye discomfort.

Side Effects

Users of Opcon-A .2675 mg/mL may experience temporary relief from eye redness and itching. The solution works quickly to reduce symptoms, providing comfort and clarity. Some users might notice a mild stinging sensation upon application, which usually subsides quickly.

Precautions & Warnings

It is important to use Opcon-A .2675 mg/mL as directed. Avoid touching the dropper tip to prevent contamination. If you experience prolonged redness or irritation, consult a healthcare professional. This product should not be used by individuals with certain eye conditions without medical advice.

Avoid Interactions

Opcon-A .2675 mg/mL may interact with other eye medications. It is advisable to wait at least 5-10 minutes between using different eye drops. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Opcon-A .2675 mg/mL is used to relieve eye redness and irritation caused by allergies or minor eye conditions.

Store Opcon-A .2675 mg/mL at room temperature, away from direct sunlight and heat.

It is generally recommended to remove contact lenses before using Opcon-A .2675 mg/mL and wait at least 15 minutes before reinserting them.

If you experience persistent or severe side effects, discontinue use and consult a healthcare professional.

Consult a healthcare professional before using Opcon-A .2675 mg/mL in children to ensure it is appropriate for their specific needs.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.